MA43298A - Derives heterocycliques d'indole pour des infections par le virus de la influenza - Google Patents
Derives heterocycliques d'indole pour des infections par le virus de la influenzaInfo
- Publication number
- MA43298A MA43298A MA043298A MA43298A MA43298A MA 43298 A MA43298 A MA 43298A MA 043298 A MA043298 A MA 043298A MA 43298 A MA43298 A MA 43298A MA 43298 A MA43298 A MA 43298A
- Authority
- MA
- Morocco
- Prior art keywords
- indole
- influenza virus
- virus infections
- heterocyclic derivatives
- heterocyclic
- Prior art date
Links
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
- 208000015181 infectious disease Diseases 0.000 title 1
- 241000712461 unidentified influenza virus Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15196811 | 2015-11-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA43298A true MA43298A (fr) | 2021-04-14 |
Family
ID=54707665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA043298A MA43298A (fr) | 2015-11-27 | 2016-11-25 | Derives heterocycliques d'indole pour des infections par le virus de la influenza |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10626108B2 (enExample) |
| EP (1) | EP3380467B1 (enExample) |
| JP (1) | JP6903658B2 (enExample) |
| KR (1) | KR20180087290A (enExample) |
| CN (1) | CN108290869B (enExample) |
| AU (1) | AU2016359907B2 (enExample) |
| CA (1) | CA3005514A1 (enExample) |
| DK (1) | DK3380467T3 (enExample) |
| EA (1) | EA201891278A1 (enExample) |
| ES (1) | ES2882671T3 (enExample) |
| HR (1) | HRP20211223T1 (enExample) |
| HU (1) | HUE055200T2 (enExample) |
| LT (1) | LT3380467T (enExample) |
| MA (1) | MA43298A (enExample) |
| SI (1) | SI3380467T1 (enExample) |
| WO (1) | WO2017089518A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GEAP202213376A (en) | 2009-06-17 | 2022-02-25 | Vertex Pharmaceuticals Incorporated Us | Inhibitors of influenza viruses replication |
| UA118010C2 (uk) | 2011-08-01 | 2018-11-12 | Вертекс Фармасьютікалз Інкорпорейтед | Інгібітори реплікації вірусів грипу |
| JP6857617B2 (ja) | 2015-05-13 | 2021-04-14 | バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ | インフルエンザウイルスの複製の阻害剤 |
| WO2016183116A1 (en) | 2015-05-13 | 2016-11-17 | Vertex Pharmaceuticals Incorporated | Methods of preparing inhibitors of influenza viruses replication |
| DK3405466T3 (da) | 2016-01-20 | 2021-02-01 | Janssen Sciences Ireland Unlimited Co | Arylsubstituerede pyrimidiner til anvendelse ved influenzavirusinfektion |
| WO2018033082A1 (en) * | 2016-08-16 | 2018-02-22 | Sunshine Lake Pharma Co., Ltd. | Inhibitors of influenza virus replication, application methods and uses thereof |
| WO2018041091A1 (en) | 2016-08-30 | 2018-03-08 | Sunshine Lake Pharma Co., Ltd. | Inhibitors of influenza virus replication, application methods and uses thereof |
| EP3555095B1 (en) | 2016-12-15 | 2023-04-12 | Sunshine Lake Pharma Co., Ltd. | Inhibitors of influenza virus replication and uses thereof |
| CA3047404A1 (en) * | 2016-12-23 | 2018-06-28 | Aquinnah Pharmaceuticals, Inc. | Compounds, compositions and methods of use |
| WO2018127096A1 (en) | 2017-01-05 | 2018-07-12 | Sunshine Lake Pharma Co., Ltd. | Inhibitors of influenza virus replication and uses thereof |
| US10927118B2 (en) | 2017-03-02 | 2021-02-23 | Sunshine Lake Pharma Co., Ltd. | Inhibitors of influenza virus replication and uses thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2532667A1 (en) | 2005-09-30 | 2012-12-12 | Vertex Pharmaceuticals Incorporated | Deazapurines useful as inhibitors of janus kinases |
| EP2040546A4 (en) * | 2006-06-22 | 2009-12-23 | Merck & Co Inc | tyrosine kinase inhibitor |
| BRPI0807087A2 (pt) | 2007-02-08 | 2014-06-10 | Tibotec Pharm Ltd | Inibidores de hcv macrocíclicos substituídos de pirimidina |
| GEAP202213376A (en) | 2009-06-17 | 2022-02-25 | Vertex Pharmaceuticals Incorporated Us | Inhibitors of influenza viruses replication |
| WO2012032065A1 (en) | 2010-09-08 | 2012-03-15 | Glaxo Group Limited | Indazole derivatives for use in the treatment of influenza virus infection |
| CN103492381A (zh) | 2010-12-16 | 2014-01-01 | 沃泰克斯药物股份有限公司 | 流感病毒复制的抑制剂 |
| JP2013545818A (ja) * | 2010-12-16 | 2013-12-26 | バーテックス ファーマシューティカルズ インコーポレイテッド | インフルエンザウイルス複製阻害物質 |
| KR101946499B1 (ko) | 2011-04-08 | 2019-02-11 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | 바이러스 감염 치료를 위한 피리미딘 유도체 |
| UA118010C2 (uk) | 2011-08-01 | 2018-11-12 | Вертекс Фармасьютікалз Інкорпорейтед | Інгібітори реплікації вірусів грипу |
| EP2858984A1 (en) | 2012-06-08 | 2015-04-15 | Vertex Pharmaceuticals Inc. | Inhibitors of influenza viruses replication |
| LT2909195T (lt) | 2012-10-16 | 2017-09-25 | Janssen Sciences Ireland Uc | Antivirusiniai rsv junginiai |
| KR102225233B1 (ko) | 2013-02-21 | 2021-03-09 | 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 | 바이러스 감염의 치료를 위한 2-아미노피리미딘 유도체 |
| DK3405466T3 (da) | 2016-01-20 | 2021-02-01 | Janssen Sciences Ireland Unlimited Co | Arylsubstituerede pyrimidiner til anvendelse ved influenzavirusinfektion |
-
2016
- 2016-11-25 CA CA3005514A patent/CA3005514A1/en not_active Abandoned
- 2016-11-25 HU HUE16801246A patent/HUE055200T2/hu unknown
- 2016-11-25 WO PCT/EP2016/078778 patent/WO2017089518A1/en not_active Ceased
- 2016-11-25 DK DK16801246.6T patent/DK3380467T3/da active
- 2016-11-25 KR KR1020187016921A patent/KR20180087290A/ko not_active Ceased
- 2016-11-25 AU AU2016359907A patent/AU2016359907B2/en not_active Ceased
- 2016-11-25 US US15/779,468 patent/US10626108B2/en not_active Expired - Fee Related
- 2016-11-25 EP EP16801246.6A patent/EP3380467B1/en active Active
- 2016-11-25 HR HRP20211223TT patent/HRP20211223T1/hr unknown
- 2016-11-25 SI SI201631276T patent/SI3380467T1/sl unknown
- 2016-11-25 EA EA201891278A patent/EA201891278A1/ru unknown
- 2016-11-25 JP JP2018527221A patent/JP6903658B2/ja not_active Expired - Fee Related
- 2016-11-25 MA MA043298A patent/MA43298A/fr unknown
- 2016-11-25 ES ES16801246T patent/ES2882671T3/es active Active
- 2016-11-25 CN CN201680068994.8A patent/CN108290869B/zh not_active Expired - Fee Related
- 2016-11-25 LT LTEPPCT/EP2016/078778T patent/LT3380467T/lt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20180087290A (ko) | 2018-08-01 |
| EP3380467A1 (en) | 2018-10-03 |
| JP6903658B2 (ja) | 2021-07-14 |
| US10626108B2 (en) | 2020-04-21 |
| US20180258074A1 (en) | 2018-09-13 |
| AU2016359907B2 (en) | 2021-04-01 |
| CA3005514A1 (en) | 2017-06-01 |
| LT3380467T (lt) | 2021-08-10 |
| WO2017089518A1 (en) | 2017-06-01 |
| DK3380467T3 (da) | 2021-09-27 |
| SI3380467T1 (sl) | 2021-08-31 |
| EA201891278A1 (ru) | 2018-11-30 |
| HUE055200T2 (hu) | 2021-11-29 |
| CN108290869A (zh) | 2018-07-17 |
| AU2016359907A1 (en) | 2018-05-24 |
| JP2019501879A (ja) | 2019-01-24 |
| EP3380467B1 (en) | 2021-07-07 |
| ES2882671T3 (es) | 2021-12-02 |
| HRP20211223T1 (hr) | 2021-11-12 |
| CN108290869B (zh) | 2021-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA43298A (fr) | Derives heterocycliques d'indole pour des infections par le virus de la influenza | |
| EP3423435A4 (en) | SUBSTITUTED INDOL-MCL-1 INHIBITORS | |
| EP3431075C0 (en) | EDARAVONDAR FORM | |
| HUE058737T2 (hu) | Eljárások arenaviridae vírusok okozta fertõzések kezelésére | |
| MA41140A (fr) | Dérivés de 2,4-dioxo-quinazoline-6-sulfonamide en tant qu'inhibiteurs de la parg | |
| EP3414224A4 (en) | INHIBITOR OF INDOLEAMINE-2,3-DIOXYGENASE (IDO) | |
| EP3436004C0 (en) | SUBSTITUTED INDOLE DERIVATIVES AS DENGUE VIRUS INHIBITORS | |
| HUE054724T2 (hu) | Mono- vagy diszubsztituált indolszármazékok dengue-vírus replikáció inhibitorokként | |
| MA45646A (fr) | Derives de benzimidazole comme des modulateurs de ror-gamma | |
| DK3630724T3 (da) | Substituerede indolinderivater som inhibitorer af virusreplikation af denguevirus | |
| EP3314590A4 (en) | ALARMING NEAR ARTICLES | |
| ZA201806482B (en) | Substituted indoline derivatives as dengue viral replication inhibitors | |
| PL3539961T3 (pl) | Policykliczne pochodne amidowe jako inhibitory CDK9 | |
| LT3601266T (lt) | Pakeisti indolino dariniai, kaip dengės viruso replikacijos inhibitoriai | |
| EP3449001A4 (en) | INHIBITION OF MIR-22-MIRNA BY APT-110 | |
| EP3502112A4 (en) | ANTI-INFLUENZA VIRUS-pyrimidine | |
| IL261943A (en) | Transformed indulin derivatives as inhibitors of dengue virus replication | |
| MA41341A (fr) | Dérivés indole utilisés en tant qu'inhibiteurs de la réplication du virus de la dengue | |
| FR3056393B1 (fr) | Orthese d'extension de machoires | |
| ME03360B (me) | Mono- ili di-supsтituisani derivaтi indola као inhibiтori replikacije virusa denge | |
| PL3625224T3 (pl) | Pochodne n-podstawionego indolu | |
| PT3457851T (pt) | Derivados de sobetiroma | |
| HUE045906T2 (hu) | Új szulfonimidoilpurinon vegyületek és származékok vírusfertõzés kezelésére és megelõzésére | |
| LT3436074T (lt) | Tiazolido junginiai, skirti virusinių infekcijų gydymui | |
| EP3397288A4 (en) | PROCESS FOR REDUCING ATAXIN-2 EXPRESSION |